REPLIGEN CORP Investment Income, Nonoperating
REPLIGEN CORP (RGEN) reported Investment Income, Nonoperating of $59.00 thousand for the 3-month period ending 2014-12-31, per its 10-K filed 2015-03-17.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2015-03-17
- REPLIGEN CORP investment income, nonoperating for the quarter ending 2014-12-31 was $59.00K, a 39.80% decline year-over-year.
- REPLIGEN CORP investment income, nonoperating for the quarter ending 2014-09-30 was $64.00K, a 15.79% decline year-over-year.
- REPLIGEN CORP investment income, nonoperating for the quarter ending 2014-06-30 was $85.00K, a 30.77% increase year-over-year.
- REPLIGEN CORP investment income, nonoperating for the quarter ending 2014-03-31 was $102.00K, a 64.52% increase year-over-year.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 3 month as first filed | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 12 month |
|---|---|---|---|---|---|
| 2014-12-31 | $59.00K 10-K · filed 2015-03-17 | $123.00K derived: sum of 2 quarters · filed 2015-03-17 | $208.00K derived: sum of 3 quarters · filed 2015-03-17 | $310.00K derived: sum of 4 quarters · filed 2015-03-17 | |
| 2014-09-30 | $64.00K 10-K · filed 2015-03-17 | $149.00K derived: sum of 2 quarters · filed 2015-03-17 | $251.00K derived: sum of 3 quarters · filed 2015-03-17 | $349.00K derived: sum of 4 quarters · filed 2015-03-17 | |
| 2014-06-30 | $85.00K 10-K · filed 2015-03-17 | $187.00K derived: sum of 2 quarters · filed 2015-03-17 | $285.00K derived: sum of 3 quarters · filed 2015-03-17 | $361.00K derived: sum of 4 quarters · filed 2015-03-17 | |
| 2014-03-31 | $102.00K 10-K · filed 2015-03-17 | $200.00K derived: sum of 2 quarters · filed 2015-03-17 | $276.00K derived: sum of 3 quarters · filed 2015-03-17 | $341.00K derived: sum of 4 quarters · filed 2015-03-17 | |
| 2013-12-31 | $98.00K 10-K · filed 2015-03-17 | $174.00K derived: sum of 2 quarters · filed 2015-03-17 | $239.00K derived: sum of 3 quarters · filed 2015-03-17 | $301.00K derived: sum of 4 quarters · filed 2015-03-17 | |
| 2013-09-30 | $76.00K 10-K · filed 2015-03-17 | $141.00K derived: sum of 2 quarters · filed 2015-03-17 | $203.00K derived: sum of 3 quarters · filed 2015-03-17 | $265.00K derived: sum of 4 quarters · filed 2015-03-17 | |
| 2013-06-30 | $65.00K 10-K · filed 2015-03-17 | $127.00K derived: sum of 2 quarters · filed 2015-03-17 | $189.00K derived: sum of 3 quarters · filed 2015-03-17 | $284.00K derived: sum of 4 quarters · filed 2015-03-17 | |
| 2013-03-31 | $62.00K 10-K · filed 2015-03-17 | $124.00K derived: sum of 2 quarters · filed 2015-03-17 | $219.00K derived: sum of 3 quarters · filed 2015-03-17 | $248.00K derived: sum of 4 quarters · filed 2015-03-17 | |
| 2012-12-31 | $62.00K 10-K · filed 2014-03-14 | $157.00K derived: sum of 2 quarters · filed 2014-03-14 | $186.00K derived: sum of 3 quarters · filed 2014-03-14 | $217.00K derived: sum of 4 quarters · filed 2014-03-14 | |
| 2012-09-30 | $95.00K 10-K · filed 2014-03-14 | $95.81K 10-Q · filed 2012-11-08 | $124.00K derived: sum of 2 quarters · filed 2014-03-14 | $156.75K 10-Q · filed 2012-11-08 | $198.00K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $29.00K 10-K · filed 2014-03-14 | $29.52K 10-Q · filed 2012-08-09 | $60.94K 10-Q · filed 2012-08-09 | $103.00K derived: sum of 3 quarters · filed 2014-03-14 | $156.00K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $31.00K 10-K · filed 2014-03-14 | $74.00K derived: sum of 2 quarters · filed 2014-03-14 | $127.00K derived: sum of 3 quarters · filed 2014-03-14 | $193.00K derived: sum of 4 quarters · filed 2014-03-14 | |
| 2011-12-31 | $43.00K 10-K · filed 2013-03-15 | $96.00K derived: sum of 2 quarters · filed 2013-03-15 | $162.00K derived: sum of 3 quarters · filed 2013-03-15 | $231.00K derived: sum of 4 quarters · filed 2013-03-15 | |
| 2011-09-30 | $53.00K 10-K · filed 2013-03-15 | $52.25K 10-Q · filed 2012-11-08 | $119.00K derived: sum of 2 quarters · filed 2013-03-15 | $187.48K 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $66.00K 10-K · filed 2013-03-15 | $65.94K 10-Q · filed 2012-08-09 | $135.24K 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | $69.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |